92 related articles for article (PubMed ID: 1969127)
1. [Cisplatin nephrotoxicity: effects on fractional excretion of sodium and enzymuria].
Cirami C; Bianchi AM; Galigani P; Gadducci A; Colombi L; Facchini V; Palla R
Minerva Med; 1990; 81(1-2):79-86. PubMed ID: 1969127
[TBL] [Abstract][Full Text] [Related]
2. [Lithium and the kidney. Acute effects on ADH secretion and enzymuria].
Palla R; Galigani P; Marchitiello M; Tuoni M; Lenzi A; Placidi GF
Minerva Med; 1986 Feb; 77(7-8):205-8. PubMed ID: 2869450
[TBL] [Abstract][Full Text] [Related]
3. [Cisplatin and ovarian carcinoma--early detection of cisplatin-induced nephrotoxicity].
Kobayashi H
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jun; 37(6):888-96. PubMed ID: 4040542
[TBL] [Abstract][Full Text] [Related]
4. The excretion of urinary enzymes, proteins and creatinine in patients receiving cisplatinum.
Nekulová M; Mechl Z; Kerpel-Fronius S; Skalková D; Sopková B
Neoplasma; 1987; 34(2):183-8. PubMed ID: 2885765
[TBL] [Abstract][Full Text] [Related]
5. Enzymuria in aminoglycoside-induced kidney damage. Comparative study of gentamicin, amikacin, sisomicin and netilmicin.
Palla R; Marchitiello M; Tuoni M; Cirami C; Giovannini L; Bertelli AA; Bertelli A
Int J Clin Pharmacol Res; 1985; 5(5):351-5. PubMed ID: 2866167
[TBL] [Abstract][Full Text] [Related]
6. [Cisplatin nephrotoxicity: clinical observation and animal experiment].
Qiu XF; Li ZX
Zhonghua Fu Chan Ke Za Zhi; 1992 Jan; 27(1):35-7, 59. PubMed ID: 1505276
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of methods for evaluating the nephrotoxicity of cisplatin].
Suzumori K; Yasui Y; Suzumori K; Yagami Y; Seki T
Gan To Kagaku Ryoho; 1988 Aug; 15(8):2251-6. PubMed ID: 3044273
[TBL] [Abstract][Full Text] [Related]
8. Cisplatin nephrotoxicity: experimental and clinical studies.
Daugaard G
Dan Med Bull; 1990 Feb; 37(1):1-12. PubMed ID: 2178884
[TBL] [Abstract][Full Text] [Related]
9. [Intraperitoneal and intrapleural two channel chemotherapy by cisplatinum (DDP) and sodium thiosulfate for the treatment of ovarian cancer].
Hatae M; Tezuka H; Ushiki N; Ezono Y; Igyuin H; Terahara M; Hokanishi H
Gan To Kagaku Ryoho; 1984 Mar; 11(3):433-9. PubMed ID: 6538403
[TBL] [Abstract][Full Text] [Related]
10. [Renal tubular function in children with hypercalciuria].
Kovacević L; Kovacević S; Smoljanić Z; Kostić M; Peco-Antić A; Gajić M; Kovacević M; Jovanović O
Srp Arh Celok Lek; 1998; 126(7-8):223-7. PubMed ID: 9863386
[TBL] [Abstract][Full Text] [Related]
11. Follow-up study of enzymuria and beta 2 microglobulinuria during cis-platinum treatment.
Tirelli AS; Colombo N; Cavanna G; Mangioni C; Assael BM
Eur J Clin Pharmacol; 1985; 29(3):313-8. PubMed ID: 3908127
[TBL] [Abstract][Full Text] [Related]
12. Comparative study of the acute nephrotoxicity from standard dose cisplatin +/- ifosfamide and high-dose chemotherapy with carboplatin and ifosfamide.
Hartmann JT; Fels LM; Franzke A; Knop S; Renn M; Maess B; Panagiotou P; Lampe H; Kanz L; Stolte H; Bokemeyer C
Anticancer Res; 2000; 20(5C):3767-73. PubMed ID: 11268452
[TBL] [Abstract][Full Text] [Related]
13. [Acute nephrotoxicity by CDDP (on tubular damage)].
Higuchi K; Negoro Y; Suzuki M; Noguchi M; Nakanishi M; Ishihara M; Nakano M
Gan To Kagaku Ryoho; 1991 Jan; 18(1):85-9. PubMed ID: 1987905
[TBL] [Abstract][Full Text] [Related]
14. [Urinary enzymologic diagnosis].
Dubach UC
Z Urol Nephrol; 1982 Jun; 75(6):401-8. PubMed ID: 6126972
[TBL] [Abstract][Full Text] [Related]
15. [Renal enzyme excretion in tumors and tumor therapy].
Dreller E; Burchardt U
Z Gesamte Inn Med; 1983 Nov; 38(21):593-9. PubMed ID: 6141672
[TBL] [Abstract][Full Text] [Related]
16. Microalbuminuria during cisplatin therapy: relation with pharmacokinetics and implications for nephroprotection.
Kern W; Braess J; Kaufmann CC; Wilde S; Schleyer E; Hiddemann W
Anticancer Res; 2000; 20(5C):3679-88. PubMed ID: 11268439
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of renal enzymuria and cellular excretion as an marker of acute nephrotoxicity due to an overdose of paracetamol in Wistar rats.
da Silva Melo DA; Saciura VC; Poloni JA; Oliveira CS; Filho JC; Padilha RZ; Reichel CL; Neto EJ; Oliveira RM; D'avila LC; Kessler A; de Oliveira JR
Clin Chim Acta; 2006 Nov; 373(1-2):88-91. PubMed ID: 16806140
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of epithelial ovarian carcinoma with cisplatin and adriamycin: analysis of factors influencing prognosis in advanced cases].
Kamura T; Tsukamoto N; Jo S; Imachi M; Kaku T; Matsukuma K; Matsuyama T
Gan To Kagaku Ryoho; 1986 Oct; 13(10):2954-9. PubMed ID: 3021066
[TBL] [Abstract][Full Text] [Related]
19. Renal function and urinary prostanoid excretions in salt-depleted women: comparative effects of enalapril and indomethacin treatments.
Agnoli GC; Borgatti R; Cacciari M; Lenzi P; Marinelli M; Stipo L
Prostaglandins Leukot Essent Fatty Acids; 1999 Feb; 60(2):87-93. PubMed ID: 10328327
[TBL] [Abstract][Full Text] [Related]
20. [Effects of combination chemotherapy with cis-diamminedichloroplatinum (II) (CDDP) on renal function in patients with urogenital malignancies].
Kawamura J; Hida S; Higashi Y; Yamauchi T; Soeda A; Yoshida O
Hinyokika Kiyo; 1985 Feb; 31(2):207-21. PubMed ID: 4040315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
